Defence Therapeutics Inc. Stock OTC Markets
Stocks
DTCF.F
CA24463V1013
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4100 USD | +2.65% |
|
+37.77% | -26.47% |
| 08-04 | Defence Therapeutics Inc. Announces Management Changes | CI |
| 08-04 | Defence Therapeutics Inc Announces CEO Changes | CI |
| Market Cap | 33.35M 23.94M 20.75M 19.42M 17.72M 2.28B 33.91M 228M 89.22M 1.14B 89.88M 87.93M 3.81B | P/E 2024 |
-2.5x | P/E 2025 | -9.9x |
|---|---|---|---|---|---|
| Enterprise Value | 33.62M 24.13M 20.91M 19.58M 17.87M 2.3B 34.18M 230M 89.95M 1.15B 90.62M 88.64M 3.84B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
66.13% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.65% | ||
| 1 week | +37.77% | ||
| Current month | +37.12% | ||
| 1 month | +26.75% | ||
| 3 months | +17.14% | ||
| 6 months | -2.38% | ||
| Current year | -26.47% |
| 1 week | 0.27 |  | 0.44 |
| 1 month | 0.25 | | 0.44 |
| Current year | 0.25 | | 0.56 |
| 1 year | 0.25 | | 0.78 |
| 3 years | 0.25 | | 2.5 |
| 5 years | 0.25 | | 6.41 |
| 10 years | 0.25 | | 6.41 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amie Phinney
CEO | Chief Executive Officer | - | 2026-07-31 |
Arnab De
DFI | Director of Finance/CFO | 55 | 2024-12-19 |
Maxime Parisotto
CTO | Chief Tech/Sci/R&D Officer | - | 2024-11-24 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 53 | 2026-07-31 | |
| Director/Board Member | 64 | 2021-01-04 | |
| Director/Board Member | - | 2024-09-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.65% | +37.77% | - | - | 21.75M | |
| -0.72% | +3.41% | +6.32% | +16.27% | 50.03B | |
| -0.69% | +6.25% | +492.36% | +585.40% | 44.36B | |
| +0.08% | +11.23% | +23.99% | +81.74% | 40.82B | |
| +0.76% | +6.85% | +35.40% | +10.92% | 39.83B | |
| +4.73% | +13.29% | +27.76% | +54.22% | 32.51B | |
| -0.41% | +4.08% | - | - | 16.85B | |
| +0.51% | +5.29% | +34.62% | +126.87% | 16.81B | |
| -0.20% | +1.57% | +5.49% | +21.35% | 14.05B | |
| +1.81% | +20.45% | +89.35% | +31.49% | 13.22B | |
| Average | +0.85% | +283.03% | +89.41% | +116.03% | 29.83B | |
| Weighted average by Cap. | +0.53% | +297.81% | +108.45% | +139.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -13.19M -9.47M -8.21M -7.68M -7.01M -903M -13.41M -90.09M -35.3M -452M -35.56M -34.79M -1.51B | -3.52M -2.53M -2.19M -2.05M -1.87M -241M -3.58M -24.05M -9.42M -121M -9.49M -9.29M -403M |
| Net Debt | 1.69M 1.21M 1.05M 984K 898K 116M 1.72M 11.54M 4.52M 57.92M 4.56M 4.46M 193M | 272K 195K 169K 158K 144K 18.61M 276K 1.86M 727K 9.32M 733K 717K 31.08M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-10 | US$0.2694 | -9.87% | 2,500 |
| 26-08-07 | US$0.2989 | +4.07% | 9,400 |
| 26-08-06 | US$0.2872 | -3.49% | 1,599 |
- Stock Market
- Stocks
- DTC Stock
- DTCF.F Stock
Select your edition
All financial news and data tailored to specific country editions
